Gorji Hasan Abolghasem, Moeini Sajad, Sheikhrobat Mohmmad Veysi, Rezapour Aziz, Souresrafil Aghdas, Barzegar Mohammad
Department of Health Services Management School of Health Management and Information Sciences, Iran University of Medical Sciences Tehran Iran.
Health Management and Economics Research Center, Health Management Research Institute Iran University of Medical Sciences Tehran Iran.
Health Sci Rep. 2025 May 5;8(5):e70815. doi: 10.1002/hsr2.70815. eCollection 2025 May.
Acute appendicitis (AA) is a prevalent cause of lower abdominal pain, often leading patients to seek emergency department care, particularly among young individuals. The present study aimed to systematically review cost-effectiveness studies focusing on therapeutic interventions for AA.
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically reviewed economic evaluations of AA treatments published between 2000 and 2020. We searched multiple databases, including Cochrane, PubMed, Scopus, and Web of Science. The studies included in this review were assessed using the Quality of Health Economic Studies (QHES) checklist, and cost data were standardized to 2022 US dollars.
Out of the 53 screened studies, 11 fulfilled the inclusion criteria. The studies' average QHES score was of high quality (0.87). Most studies were from the payer's perspective and the health system (four studies each). Five studies were based on the decision tree model, and three were based on the Markov model. Four studies were conducted on children. Of the 11 studies reviewed, five support the cost-effectiveness of laparoscopy, five support the cost-effectiveness of antibiotic therapy, and one supports the cost-effectiveness of open appendectomy.
Based on the findings of this study, laparoscopic therapeutic intervention, compared to open appendectomy, can be more cost-effective for the treatment of patients with AA.
急性阑尾炎(AA)是下腹部疼痛的常见原因,常导致患者前往急诊科就诊,在年轻人中尤为常见。本研究旨在系统评价聚焦于AA治疗性干预措施的成本效益研究。
按照系统评价与Meta分析的首选报告项目(PRISMA)指南,我们系统评价了2000年至2020年间发表的AA治疗的经济学评价。我们检索了多个数据库,包括Cochrane、PubMed、Scopus和Web of Science。本评价纳入的研究使用卫生经济研究质量(QHES)清单进行评估,成本数据标准化为2022年美元。
在筛选的53项研究中,11项符合纳入标准。这些研究的平均QHES评分为高质量(0.87)。大多数研究是从支付方和卫生系统的角度进行的(各有四项研究)。五项研究基于决策树模型,三项基于马尔可夫模型。四项研究是针对儿童进行的。在纳入评价的11项研究中,五项支持腹腔镜手术的成本效益,五项支持抗生素治疗的成本效益,一项支持开腹阑尾切除术的成本效益。
基于本研究的结果,与开腹阑尾切除术相比,腹腔镜治疗性干预对AA患者的治疗可能更具成本效益。